Trans-Oral Robotic Surgery for Early Oropharyngeal Cancer
Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- Royal Marsden NHS Foundation Trust · Other
This trial is looking for adults with early-stage squamous cell cancer in the oropharynx. Participants must have had a specific type of surgery, and may also opt to take part in additional studies about genetics and imaging.
You may be able to join if
- I am 18 years or older.
- I have a primary tumour in the oropharynx.
- I have been diagnosed with squamous cell carcinoma.
- My tumour is either P16 positive or negative.
- I have been treated with trans-oral robotic surgery.
- My cancer is at an early stage (pT1-T2).
- My surgery was done on or before December 31, 2021.
You may not be able to join if
- I have moderate to advanced stage oropharyngeal cancer.
- I had surgery for diagnosis, recurrence, or palliative care.
- I have a prior history of head and neck cancer or radiation therapy.
- I have known distant metastatic disease.
- I have other types of head and neck cancers.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityMulti-centre retrospective observational cohort study with optional exploratory radiomic study (international) and prospective molecular analysis studies (UK only).
Loading trial locations…